Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,822,480
+$3,627,698 QoQ
Shares Held
24,366
+103.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#212
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $237,530,945 across 13 Diagnostics & Research names. LH ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
206,814 | $103,688,267 | |
| 2 | A |
Agilent Technologies, Inc.
|
440,703 | $58,538,579 | |
| 3 | DHR |
Danaher Corp /De/
|
165,310 | $31,488,248 | |
| 4 | NTRA |
Natera, Inc.
|
44,200 | $11,998,090 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
24,366 | $6,822,480 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
8,327 | $4,383,665 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
3,306 | $4,223,448 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
16,667 | $3,779,908 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,822,480 | 24,366 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,194,782 | 11,974 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,606,650 | 14,376 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,344,822 | 11,652 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,665,788 | 10,155 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,318,788 | 9,963 | Shares | Defined | 2025-07-02 | |
| 2024-12-31 | $6,346,430 | 27,675 | Shares | Sole | 2025-07-02 | |
| 2024-09-30 | $2,738,747 | 12,255 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,739,019 | 52,769 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||